Significant Options Activity in PTC, Evolus, and ServiceNow

Analyzing options trading among the Russell 3000 index components reveals notable activity today, particularly with PTC Therapeutics Inc (Symbol: PTCT). So far, 6,052 contracts have changed hands, equating to about 605,200 underlying shares. This trading volume represents 49.1% of PTCT’s average daily trading volume of 1.2 million shares over the past month. A significant portion of this activity involves the $60 strike call option expiring on May 16, 2025, where 3,018 contracts have been traded, representing roughly 301,800 underlying shares of PTCT.

Below is a chart illustrating PTCT’s trailing twelve-month trading history, with the $60 strike highlighted in orange:

Evolus Inc (Symbol: EOLS) has also experienced significant options trading with a total of 5,186 contracts. This volume corresponds to approximately 518,600 underlying shares, or about 49% of EOLS’s average daily trading volume of 1.1 million shares over the past month. Notably, the $12.50 strike call option expiring on July 18, 2025, saw an especially high volume, with 5,000 contracts trading, representing around 500,000 underlying shares of EOLS.

Below is a chart displaying EOLS’s trailing twelve-month trading history, with the $12.50 strike highlighted in orange:

Furthermore, ServiceNow Inc (Symbol: NOW) is also witnessing considerable options activity today, with a volume of 10,836 contracts. This volume translates to approximately 1.1 million underlying shares, representing 45.6% of NOW’s average daily trading volume of 2.4 million shares over the past month. High volume has been recorded for the $1000 strike call option expiring on May 2, 2025, where 858 contracts have traded, corresponding to about 85,800 underlying shares of NOW.

Here is a chart that shows NOW’s trailing twelve-month trading history, with the $1000 strike highlighted in orange:

For additional information on expiration dates for PTCT, EOLS, or NOW options, visit StockOptionsChannel.com.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.